Author

Ruidong Hao

ORCID 0009-0000-7319-3657Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Bo ZhaiiD· 1 shared Hongye WangiD· 1 shared Minmin SuniD· 1 shared Shuangshuang ZhangiD· 1 shared Yantao LiiD· 1 shared Youtao Wang· 1 shared Yuanguo Cheng· 1 shared Yunpeng Zhong· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Bo ZhaiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintMay 17, 2023

Enhancing anti-gastrointestinal cancer activities of CLDN18.2 CAR-T armored with novel synthetic NKG2D receptors Containing DAP10 and DAP12 signaling domains.

Minmin Sun, Hongye Wang, Ruidong Hao…·Yuanguo Cheng

This paper develops a CAR-T therapy for gastrointestinal cancers by combining CLDN18.2 targeting with synthetic NKG2D receptors containing DAP10 and DAP12 domains, improving efficacy against heterogeneous tumors.

DOI 10.1101/2023.05.17.541124

mouseproteomics

𝕏 PostBluesky